14 October 2021
VEROVACCiNES closes Series B financing with consortium of investors from Germany and Switzerland
- Vaccine specialist closes Mid-Seven-Figure Series B Financing Round
- Shareholder group expanded by four new investors with important expertise
- The fresh funding will be used to drive several vaccine programs into regulatory development